Investar (ISTR) Just Flashed Golden Cross Signal: Do You Buy?

In this article:

From a technical perspective, Investar Holding Corporation (ISTR) is looking like an interesting pick, as it just reached a key level of support. ISTR's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

Golden crosses have three key stages that investors look out for. It starts with a downtrend in a stock's price that eventually bottoms out, followed by the stock's shorter moving average crossing over its longer moving average and triggering a trend reversal. The final stage is when a stock continues the upward climb to higher prices.

A golden cross is the opposite of a death cross, another technical event that indicates bearish price movement may be on the horizon.

Shares of ISTR have been moving higher over the past four weeks, up 7.2%. Plus, the company is currently a #1 (Strong Buy) on the Zacks Rank, suggesting that ISTR could be poised for a breakout.

The bullish case solidifies once investors consider ISTR's positive earnings outlook. For the current quarter, no earnings estimate has been cut compared to 3 revisions higher in the past 60 days. The Zacks Consensus Estimate has increased too.

Moving Average Chart for ISTR
Moving Average Chart for ISTR

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on ISTR for more gains in the near future.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Investar Holding Corporation (ISTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement